CLINICAL_TRIALS
trial_result
· 2019-03-12
Clinical Trial Update: Safety Study of SPARC1104 [Phase 3]
Summary
Phase 3 safety study of SPARC1104 for spasticity has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Pharma Advanced Research Company Limited | Conditions: Spasticity | Phase 3 | Status: COMPLETED | Results posted: 2019-03-12